Gene probe for alveolar soft part sarcoma and application of gene probe kit

Abstract

The invention relates to a gene probe for alveolar soft part sarcoma and application of a gene probe kit. Clonal fragments selected and used by the gene probe are RP11-634L10, RP11-51H16 and RP11-475F12 combination as well as CTD-2311N12, RP11-416B14, CTD-2522M13, CTD-2312C1 and CTD-2248C21 combination respectively. According to the gene probe, the defects of an influence on prognostic and postoperative treatment and the like due to a tedious and time-consuming RT-PCR (reverse transcription-polymerase chain reaction) and cell karyotype analysis method, limitation of RT-PCR application by RNA degradation and numerous other factors, and inaccurate diagnosis are overcome; the gene probe is high in accuracy, specificity and success rate, strong in fluorescent signal and easy and convenient to operate, and can be applied to paraffin sections; the specimen detection range is extended, a novel method for accurately, reliably, simply and conveniently diagnosing the alveolar soft part sarcoma is built, and a precedent for detecting the alveolar soft part sarcoma by FISH (fluorescence in situ hybridization) is created.

Description

technical field [0001] The invention belongs to the application field of fluorescent in situ hybridization probes, in particular to gene probes for alveolar soft tissue sarcoma and the application of kits thereof. Background technique [0002] Alveolar soft tissue sarcoma is a rare malignant soft tissue sarcoma of unknown origin that occurs in children and young adults. The main symptom is a soft tissue mass that grows slowly. Balanced translocation, namely: der(17)t(X;17)(p11.2;q25), resulting in translocation of the TFE3 telomeric side gene at Xp11.2 to 17q25 after duplication, and with the centromere of the 17q25ASPL gene Lateral fusions form the ASPL-TFE3 fusion gene. Most patients with alveolar soft tissue sarcoma are prone to distant metastasis after discovery and treatment, and are not sensitive to radiotherapy and chemotherapy. The overall prognosis is poor. The 5-year, 10-year, and 20-year survival rates are 60%, 38%, and 15%, respectively Therefore, accurate diag...

AI Technical Summary

Problems solved by technology

Alveolar soft tissue sarcoma with typical histological morphology is easier to diagnose, and some tumor tissues lack typical morphological manifestations, which need to be associated with paraganglioma, granular cell tumor, XP11.2 translocation / TFE3 gene fusion-related renal cancer and melanoma Differentiate different phases of tumors, especially in cases of rare disease sites, metastatic lesions, and few fine-needle aspiration biopsy tissues

Acinar soft tissue sarcoma forms an ASPL-TFE3 fusion gene, resulting in the overexpression of TFE3 protein. Therefore, TFE3 immunohistochemical detection has certain specificity for acinar soft tissue sarcoma, but in other tumors such as XP11.2 translocation / TFE3 gene Positive results of TFE3 immunohistochemistry can also be found in tissues such as fusion-related renal carcinoma, granulosa cell tumor, adrenocortical carcinoma, perivascular epithelioid cell tumor, and high-grade myxofibrosarcoma, so TFE3 immunohistochemistry can only be used as a diagnostic marker for glandular tumors. Auxiliary basis for vesicular soft tissue sarcoma

[0004] For alveolar soft tissue sarcoma, its specific gene change type is an important basis for its diagnosis. Only RT-PCR and cell karyotype analysis can achieve the purpose of diagnosis more accurately, but the karyotype analysis must be performed after tumor resection. After the tumor cells are cultured to the mitotic stage, the karyotype analysis of the tumor cells is performed using techniques such as G-banding. This method is cumbersome and time-consuming and is not suitable for clinical application.

Similarly, considering the rarity of alveolar soft tissue sarcoma and the complexity of the PCR test process, it is impossible to routinely use RT-PCR to detect the ASPL-TFE3 fusion gene in alveolar soft tissue sarcoma tissue. In sarcoma, RNA can only be extracted from paraffin sections. RNA degradation and many other factors limit the application of RT-PCR, and the technology is complicated and not suitable for wide application.

[0005] These limitations lead to some patients with suspected alveolar soft tissue sarcoma cannot be accurately diagnosed, affecting clinicians' prognosis and postoperative management of patients with alveolar soft tissue sarcoma

Images